Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK Journal:Bioorganic and Medicinal Chemistry Letters | 2016 | ||
Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent Journal:ACS Medicinal Chemistry Letters | Liu, YongLaufer, RadoslawPatel, Narendra KumarNg, GraceSampson, Peter B.Li, Sze WanLang, YunhuiFeher, MiklosBrokx, RichardBeletskaya, IrinaHodgson, RichardPlotnikova, OlgaAwrey, Donald E.Qiu, WeiChirgadze, Nickolay Y.Mason, Jacqueline M.Wei, XinLin, Dan Chi ChiaChe, YiKiarash, RezaFletcher, Graham C.Mak, Tak W.Bray, Mark R.Pauls, Henry W. | 2016 | |
Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer Journal:Proceedings of the National Academy of Sciences of the United States of America | 2017 | ||
2019 |